AAAAAA
Results: 1-25/91
Authors:
KOOPS HS
EGGERMONT AMM
LIENARD D
KROON BBR
HOEKSTRA HJ
VANGEEL AN
NIEWEG OE
LEJEUNE FJ
Citation: Hs. Koops et al., HYPERTHERMIC ISOLATED LIMB PERFUSION FOR THE TREATMENT OF SOFT-TISSUESARCOMAS, Seminars in surgical oncology, 14(3), 1998, pp. 210-214
Authors:
MANUSAMA ER
NOOIJEN PTGA
TENHAGEN TLM
VANDERVEEN AH
DEVRIES MWR
DEWILT JHW
VANIJKEN MG
MARQUET RL
EGGERMONT AMM
Citation: Er. Manusama et al., TUMOR-NECROSIS-FACTOR-ALPHA IN ISOLATED PERFUSION SYSTEMS IN THE TREATMENT OF CANCER - THE ROTTERDAM PRECLINICAL-CLINICAL PROGRAM, Seminars in surgical oncology, 14(3), 1998, pp. 232-237
Authors:
VANDEVRIE W
MARQUET RL
STOTER G
DEBRUIJN EA
EGGERMONT AMM
Citation: W. Vandevrie et al., IN-VIVO MODEL SYSTEMS IN P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE, Critical reviews in clinical laboratory sciences, 35(1), 1998, pp. 1-57
Authors:
EGGERMONT AMM
KIRKWOOD JM
Citation: Amm. Eggermont et Jm. Kirkwood, MALIGNANT-MELANOMA - CURRENT CONTROVERSIES, FUTURE PERSPECTIVES - PROCEEDINGS OF A SYMPOSIUM HELD 27-28 FEBRUARY 1997, BARCELONA, SPAIN - INTRODUCTION, European journal of cancer, 34, 1998, pp. 1-2
Authors:
EGGERMONT AMM
Citation: Amm. Eggermont, STRATEGY OF THE EORTC-MCG TRIAL PROGRAM FOR ADJUVANT TREATMENT OF MODERATE-RISK AND HIGH-RISK MELANOMA, European journal of cancer, 34, 1998, pp. 22-26
Authors:
DEWILT JHW
MANUSAMA ER
VANTIEL ST
VANIJKEN MGA
TENHAGEN TLM
EGGERMONT AMM
Citation: Jhw. Dewilt et al., PREREQUISITES FOR EFFECTIVE ISOLATED LIMB PERFUSION USING TUMOR-NECROSIS-FACTOR-ALPHA AND MELPHALAN IN RATS, European journal of cancer, 34, 1998, pp. 165-165
Authors:
VANIJKEN MGA
DEBRUIJN EA
WIGGERS T
VANEIJCK CHJ
VANDERSIJP JRM
TENHAGEN TLM
EGGERMONT AMM
Citation: Mga. Vanijken et al., HYPOXIC PERFUSION OF PELVIS, ABDOMEN AND LIVER WITH TNF-ALPHA MELPHALAN AND MITOMYCIN-C USING NEW BALLOON CATHETER TECHNIQUES - PHARMACOKINETICS IN PIGS, European journal of cancer, 34, 1998, pp. 180-180
Authors:
GIEZEMANSMITS KM
JONGES LE
CHAMBERS WH
BRISETTESTORKUS CS
VANVLIERBERGHE RLP
VANEENDENBURG JDH
EGGERMONT AMM
FLEUREN GJ
KUPPEN PJK
Citation: Km. Giezemansmits et al., NOVEL MONOCLONAL-ANTIBODIES AGAINST MEMBRANE STRUCTURES THAT ARE PREFERENTIALLY EXPRESSED ON IL-2-ACTIVATED RAT NK CELLS, Journal of leukocyte biology, 63(2), 1998, pp. 209-215
Authors:
KOOPS HS
VAGLINI M
SUCIU S
KROON BBR
THOMPSON JF
GOHL J
EGGERMONT AMM
DIFILIPPO F
KREMENTZ ET
RUITER D
LEJEUNE FJ
Citation: Hs. Koops et al., PROPHYLACTIC ISOLATED LIMB PERFUSION FOR LOCALIZED, HIGH-RISK LIMB MELANOMA - RESULTS OF A MULTICENTER RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 16(9), 1998, pp. 2906-2912
Authors:
KEILHOLZ U
CONRADT C
LEGHA SS
KHAYAT D
SCHEIBENBOGEN C
THATCHER N
GOEY SH
GORE M
DORVAL T
HANCOCK B
PUNT CJA
DUMMER R
AVRIL MF
BROCKER EB
BENHAMMOUDA A
EGGERMONT AMM
PRITSCH M
Citation: U. Keilholz et al., RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 2921-2929
Authors:
VANDERVEEN AH
EGGERMONT AMM
TENHAGEN TLM
Citation: Ah. Vanderveen et al., STEALTH(R) LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOLID TUMOR TREATMENT, International journal of pharmaceutics, 162(1-2), 1998, pp. 87-94
Authors:
AVONTUUR JAM
STAM TC
JONGENLAVRENCIC M
VANAMSTERDAM JGC
EGGERMONT AMM
BRUINING HA
Citation: Jam. Avontuur et al., EFFECT OF L-NAME, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS, ON PLASMA-LEVELS OF IL-6, IL-8, TNF-ALPHA AND NITRITE NITRATE IN HUMAN SEPTIC SHOCK/, Intensive care medicine, 24(7), 1998, pp. 673-679
Authors:
KOOPS HS
EGGERMONT AMM
LIENARD D
KROON BBR
HOEKSTRA HJ
VANGEEL AN
NIEWEG OE
LEJEUNE FJ
Citation: Hs. Koops et al., HYPERTHERMIC ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR AND MELPHALAN AS TREATMENT OF LOCALLY ADVANCED OR RECURRENT SOFT-TISSUE SARCOMAS OF THE EXTREMITIES, Radiotherapy and oncology, 48(1), 1998, pp. 1-4
Authors:
MANUSAMA ER
NOOIJEN PTGA
STAVAST J
DEWILT JHW
MARQUET RL
EGGERMONT AMM
Citation: Er. Manusama et al., ASSESSMENT OF THE ROLE OF NEUTROPHILS ON THE ANTITUMOR EFFECT OF TNF-ALPHA IN AN IN-VIVO ISOLATED LIMB PERFUSION MODEL IN SARCOMA-BEARING BROWN-NORWAY RATS, The Journal of surgical research (Print), 78(2), 1998, pp. 169-175
Authors:
HAGENAARS M
ZWAVELING S
KUPPEN PJK
ENSINK NG
EGGERMONT AMM
HOKLAND ME
BASSE PH
VANDEVELDE CJH
FLEUREN GJ
NANNMARK U
Citation: M. Hagenaars et al., CHARACTERISTICS OF TUMOR INFILTRATION BY ADOPTIVELY TRANSFERRED AND ENDOGENOUS NATURAL-KILLER-CELLS IN A SYNGENEIC RAT MODEL - IMPLICATIONSFOR THE MECHANISM BEHIND ANTITUMOR RESPONSES, International journal of cancer, 78(6), 1998, pp. 783-789
Authors:
VANDERVEEN AH
EGGERMONT AMM
SEYNHAEVE ALB
VANTIEL ST
TENHAGEN TLM
Citation: Ah. Vanderveen et al., BIODISTRIBUTION AND TUMOR-LOCALIZATION OF STEALTH LIPOSOMAL TUMOR-NECROSIS-FACTOR-ALPHA IN SOFT-TISSUE SARCOMA-BEARING RATS, International journal of cancer, 77(6), 1998, pp. 901-906
Authors:
HAGENAARS M
ENSINK NG
KOELEMIJ R
BASSE PH
EGGERMONT AMM
VANDEVELDE CJH
FLEUREN GJ
KUPPEN PJK
Citation: M. Hagenaars et al., REGIONAL ADMINISTRATION OF NATURAL-KILLER-CELLS IN A RAT HEPATIC METASTASIS MODEL RESULTS IN BETTER TUMOR INFILTRATION AND ANTITUMOR RESPONSE THAN SYSTEMIC ADMINISTRATION, International journal of cancer, 75(2), 1998, pp. 233-238
Authors:
VANROOZENDAAL CEP
GILLIS AJM
KLIJN JGM
VANOOIJEN B
CLAASSEN CJC
EGGERMONT AMM
HENZENLOGMANS SC
OOSTERHUIS JW
FOEKENS JA
LOOIJENGA LHJ
Citation: Cep. Vanroozendaal et al., LOSS OF IMPRINTING OF IGF2 AND NOT H19 IN BREAST-CANCER, ADJACENT NORMAL TISSUE AND DERIVED FIBROBLAST-CULTURES, FEBS letters, 437(1-2), 1998, pp. 107-111
Authors:
FEELDERS RA
VREUGDENHIL G
EGGERMONT AMM
KUIPERKRAMER PA
VANEIJK HG
SWAAK AJG
Citation: Ra. Feelders et al., REGULATION OF IRON-METABOLISM IN THE ACUTE-PHASE RESPONSE - INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA INDUCE HYPOFERREMIA, FERRITIN PRODUCTION AND A DECREASE IN CIRCULATING TRANSFERRIN RECEPTORS IN CANCER-PATIENTS, European journal of clinical investigation, 28(7), 1998, pp. 520-527
Authors:
NOOIJEN PTGA
EGGERMONT AMM
SCHALKWIJK L
HENZENLOGMANS S
DEWAAL RMW
RUITER DJ
Citation: Ptga. Nooijen et al., COMPLETE RESPONSE OF MELANOMA-IN-TRANSIT METASTASIS AFTER ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR-ALPHA AND MELPHALAN WITHOUT MASSIVE TUMOR NECROSIS - A CLINICAL AND HISTOPATHOLOGICAL STUDY OF THE DELAYED-TYPE REACTION PATTERN, Cancer research, 58(21), 1998, pp. 4880-4887
Authors:
NOOIJEN PTGA
WESTPHAL JR
EGGERMONT AMM
SCHALKWIJK C
MAX R
DEWAAL RMW
RUITER DJ
Citation: Ptga. Nooijen et al., ENDOTHELIAL P-SELECTIN EXPRESSION IS REDUCED IN ADVANCED PRIMARY MELANOMA AND MELANOMA METASTASIS, The American journal of pathology, 152(3), 1998, pp. 679-682
Authors:
KEILHOLZ U
STOTER G
PUNT CJA
SCHEIBENBOGEN C
LEJEUNE F
EGGERMONT AMM
Citation: U. Keilholz et al., RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP, The cancer journal from Scientific American, 3, 1997, pp. 22-28
Authors:
KRUIT WHJ
GOEY SH
LAMERS CHJ
GRATAMA JW
VISSER B
SCHMITZ PIM
EGGERMONT AMM
BOLHUIS RLH
STOTER G
Citation: Whj. Kruit et al., HIGH-DOSE REGIMEN OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN COMBINATION WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH METASTATIC RENAL-CELL-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 20(4), 1997, pp. 312-320
Authors:
EGGERMONT AMM
Citation: Amm. Eggermont, FOREWORD - THE EORTC-MELANOMA-COOPERATIVE-GROUP, Melanoma research, 7, 1997, pp. 1-1
Authors:
EGGERMONT AMM
Citation: Amm. Eggermont, THE CURRENT EORTC-MELANOMA-COOPERATIVE-GROUP ADJUVANT TRIAL PROGRAM ON MALIGNANT-MELANOMA - PROGNOSIS VERSUS EFFICACY, TOXICITY AND COSTS, Melanoma research, 7, 1997, pp. 127-131